Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants

Recruiting now · Phase 1/Phase 2 · Has a placebo group

Conditions studied: MASH

In brief

Two-part Phase 1/2 study of OPK-88006, including an open-label SAD phase in healthy participants and a double-blind, randomized, placebo-controlled MAD phase in participants with presumed MASH, to evaluate safety, PK, and MASH related pharmacodynamic changes compared to placebo.

Key facts

Study ID
NCT07512427
Run by
OPKO Health, Inc.
People needed
30
Starts
2026-07-24
Expected to finish
2027-12-01
Last updated by the study team
2026-07-31

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.